Viewing Study NCT02433093


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2025-12-27 @ 2:58 AM
Study NCT ID: NCT02433093
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2015-04-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module